Mannatech (NASDAQ:MTEX) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a research note released on Tuesday. The firm issued a buy rating on the stock.

Mannatech Price Performance

NASDAQ MTEX opened at $7.86 on Tuesday. The company has a current ratio of 1.25, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44. Mannatech has a 1 year low of $6.75 and a 1 year high of $10.51. The company has a market cap of $14.78 million, a PE ratio of -9.70 and a beta of 1.17. The stock’s 50-day moving average price is $7.85 and its two-hundred day moving average price is $7.56.

Mannatech (NASDAQ:MTEX) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) earnings per share (EPS) for the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%. The firm had revenue of $31.73 million for the quarter.

Insider Transactions at Mannatech

In other news, Director Larry A. Jobe sold 16,288 shares of the stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the sale, the director now directly owns 54,721 shares of the company’s stock, valued at $424,087.75. This represents a 22.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 41.50% of the stock is currently owned by insiders.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.